[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

Risk-taker’s market? Why it may be practical to take chips off the table

[#item_full_content]Two market experts tackle the appropriate appetite for risk during market ugliness.

‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles

[#item_full_content]Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.

Risk-taker’s market? Why it may be practical to take chips off the table

[#item_full_content]Two market experts tackle the appropriate appetite for risk during market ugliness.

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]